Xenetic Biosciences, Inc. (XBIO)

2.44 +0.02 (+0.83%) USD  |  NASDAQ  |  Dec 12, 16:00
2.43 -0.01 (-0.41%) After-Hours: 20:00
More

Xenetic Biosciences Revenue Estimates for Current Fiscal Year

Revenue Estimates for Current Fiscal Year Chart

View Revenue Estimates for Current Fiscal Year for XBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Fiscal Year Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Revenue Estimates for Current Fiscal Year Range, Past 5 Years

View Revenue Estimates for Current Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Fiscal Year Benchmarks

View Revenue Estimates for Current Fiscal Year Benchmarks
Start Trial
Iovance Biotherapeutics, Inc. Upgrade
Travere Therapeutics, Inc. Upgrade
KalVista Pharmaceuticals, Inc. Upgrade
BeyondSpring, Inc. Upgrade
Solid Biosciences, Inc. Upgrade

Revenue Estimates for Current Fiscal Year Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Next Fiscal Year Upgrade